Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015- New Product Launch

Date: 21-08-2026 BSE Limited, Floor 25, P. J. Towers, Dalal Street, Mumbai – 400001 Scrip Code: 543963 Subject: Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 – New Product Launch. Pursuant to Regulation 30 read with schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform the exchange that we are launching the new Ayurvedic Herbal Human Healthcare product on 20th August, 2026 Our company has achieved a significant milestone as R&D team of our company developed Herbal Human Healthcare product: SHELTIDIN DS – Cough Spray is a herbal throat-soothing spray formulated to provide fast and effective relief from dry and irritating cough, sore throat, throat irritation, hoarseness of voice, and everyday throat discomfort. The product's spray-based delivery format is designed to provide soothing comfort directly to the throat for convenient use. In this regard, we are pleased to inform that the said product has now been successfully launched and is available on reputed e-commerce platforms, with effect from 20th August, 2026. With a legacy of over 60 years in the pharmaceutical and healthcare industry, the Company has consistently focused on research, innovation and quality-driven manufacturing to develop products that contribute to consumer health and well-being. The Company's manufacturing facilities operate in accordance with applicable Good Manufacturing Practices (GMP) approved by FDA and relevant ISO standards, reflecting its commitment to maintaining high standards of quality, safety and regulatory compliance. The newly launched products have been developed by the Company's in-house Research & Development team for the domestic market, the Company may explore opportunities in the international market in due course. This product launch reinforces the Company's commitment to innovation, enhances its presence in international markets, and supports its long-term growth strategy while continuing to create sustainable value for its stakeholders. Kindly refer to Annexure 1 to further details of the New Product Launch. Kindly take the same on record. Thanking You, FOR SHELTER PHARMA LIMITED MUSTAQIM NISARAHMED SABUGAR MANAGING DIRECTOR DIN: 01456841 Place: Ahmedabad Date: 21st August, 2026 Annexure 1 – Disclosure under Regulation 30 of SEBI read with Schedule III (Listing Obligations and Disclosure Requirements) Regulations, 2015 Sr. No. Particulars Details 1. Name of the Products SHELTIDIN DS 2. Date of launch 20th August, 2026 3. Category of the product Herbal Human Healthcare 4. Whether caters to domestic Currently, the product caters to the international market domestic market. The Company may explore opportunities in the international market in due course. 5. Name of the countries in which the NA product is launched (in case of international).